Senior awareness gap threatens uptake of Medicare GLP-1 bridge program

Despite the upcoming July 1 start of CMS's temporary Medicare GLP-1 bridge program, which offers weight-loss drugs for a $50 monthly copay, surveys indicate many beneficiaries are unaware of the new benefit. The program's enrollment window is limited, and a lack of patient awareness could lead to low uptake and patient inquiries at the point of prescribing. This information gap presents a downstream burden for practices, which may need to field questions and help eligible patients navigate enrollment.